Cliniques universitaires Saint-Luc- Université Catholique de Louvain Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2012
NCT02570789
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

pazopanib (votrient) (1 trial)

sunitinib (sutent) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 4)

Carcinoma, Renal Cell (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2